Umeclidinium Interactions
There are 102 drugs known to interact with umeclidinium, along with 3 disease interactions. Of the total drug interactions, 101 are moderate, and1 is minor.
- View all 102 medications that may interact with umeclidinium
- View umeclidinium disease interactions (3)
Most frequently checked interactions
View interaction reports for umeclidinium and the medicines listed below.
- Advair Diskus (fluticasone / salmeterol)
- Anoro Ellipta (umeclidinium / vilanterol)
- Breo Ellipta (fluticasone / vilanterol)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Copper (copper gluconate)
- Crestor (rosuvastatin)
- Dulera (formoterol / mometasone)
- DuoNeb (albuterol / ipratropium)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flonase (fluticasone nasal)
- Glycerol (glycerin)
- Lipitor (atorvastatin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Myrbetriq (mirabegron)
- ProAir HFA (albuterol)
- Quercetin (bioflavonoids)
- Qvar RediHaler (beclomethasone)
- Spiriva (tiotropium)
- Symbicort (budesonide / formoterol)
- Synthroid (levothyroxine)
- Trelegy Ellipta (fluticasone / umeclidinium / vilanterol)
- Tylenol (acetaminophen)
- Ventolin HFA (albuterol)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Xarelto (rivaroxaban)
Umeclidinium disease interactions
There are 3 disease interactions with umeclidinium which include:
More about umeclidinium
- umeclidinium consumer information
- Compare alternatives
- Reviews (36)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anticholinergic bronchodilators
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.